1. Home
  2. NEGG vs SDGR Comparison

NEGG vs SDGR Comparison

Compare NEGG & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newegg Commerce Inc.

NEGG

Newegg Commerce Inc.

HOLD

Current Price

$20.40

Market Cap

883.1M

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$13.33

Market Cap

925.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEGG
SDGR
Founded
2001
1990
Country
United States
United States
Employees
762
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
883.1M
925.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NEGG
SDGR
Price
$20.40
$13.33
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$21.00
AVG Volume (30 Days)
82.0K
1.3M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
N/A
$255,869,000.00
Revenue This Year
N/A
$0.76
Revenue Next Year
N/A
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.29
52 Week Low
$4.82
$10.95
52 Week High
$137.84
$27.63

Technical Indicators

Market Signals
Indicator
NEGG
SDGR
Relative Strength Index (RSI) 24.75 61.15
Support Level N/A $11.18
Resistance Level $58.12 $13.36
Average True Range (ATR) 2.37 0.66
MACD -0.42 0.04
Stochastic Oscillator 10.82 85.17

Price Performance

Historical Comparison
NEGG
SDGR

About NEGG Newegg Commerce Inc.

Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: